Loading...

Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

Treatment of glioblastoma (GBM), the most common primary malignant brain tumor in adults, remains a significant unmet need in oncology. Historically, cytotoxic treatments provided little durable benefit, and tumors recurred within several months. This has spurred a substantial research effort to est...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Lu-Emerson, Christine, Duda, Dan G., Emblem, Kyrre E., Taylor, Jennie W., Gerstner, Elizabeth R., Loeffler, Jay S., Batchelor, Tracy T., Jain, Rakesh K.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517055/
https://ncbi.nlm.nih.gov/pubmed/25713439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.9575
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!